Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Levothyroxine sodium
Medication labelHypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in…
Why this: Advisory · dailymed-prescription
Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions (5.1)]. Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
- generic_name
- levothyroxine sodium
- product_names
- levothyroxine sodium
- ndc
- 42292-038, 0378-1807, 42292-038-01, 42292-038-20, 42292-039, 0378-1811, 42292-039-01, 42292-039-20, 42292-041, 0378-1823, 42292-041-01, 42292-041-20, 42292-040, 0378-1817, 42292-040-01, 42292-040-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en